Global Cancer Biopsy Market Growth (Status and Outlook) 2023-2028

Report ID: 1270369 | Published Date: Jan 2025 | No. of Page: 114 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Cancer Biopsy Market Size 2017-2028
        2.1.2 Cancer Biopsy Market Size CAGR by Region 2017 VS 2022 VS 2028
    2.2 Cancer Biopsy Segment by Type
        2.2.1 Tissue Biopsies
        2.2.2 Liquid Biopsies
        2.2.3 Others
    2.3 Cancer Biopsy Market Size by Type
        2.3.1 Cancer Biopsy Market Size CAGR by Type (2017 VS 2022 VS 2028)
        2.3.2 Global Cancer Biopsy Market Size Market Share by Type (2017-2022)
    2.4 Cancer Biopsy Segment by Application
        2.4.1 Breast Cancer
        2.4.2 Colorectal Cancer
        2.4.3 Cervical Cancers
        2.4.4 Lung Cancers
        2.4.5 Prostate Cancers
        2.4.6 Skin Cancers
        2.4.7 Blood Cancers
        2.4.8 Kidney Cancers
        2.4.9 Others
    2.5 Cancer Biopsy Market Size by Application
        2.5.1 Cancer Biopsy Market Size CAGR by Application (2017 VS 2022 VS 2028)
        2.5.2 Global Cancer Biopsy Market Size Market Share by Application (2017-2022)
3 Cancer Biopsy Market Size by Player
    3.1 Cancer Biopsy Market Size Market Share by Players
        3.1.1 Global Cancer Biopsy Revenue by Players (2020-2022)
        3.1.2 Global Cancer Biopsy Revenue Market Share by Players (2020-2022)
    3.2 Global Cancer Biopsy Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion
4 Cancer Biopsy by Regions
    4.1 Cancer Biopsy Market Size by Regions (2017-2022)
    4.2 Americas Cancer Biopsy Market Size Growth (2017-2022)
    4.3 APAC Cancer Biopsy Market Size Growth (2017-2022)
    4.4 Europe Cancer Biopsy Market Size Growth (2017-2022)
    4.5 Middle East & Africa Cancer Biopsy Market Size Growth (2017-2022)
5 Americas
    5.1 Americas Cancer Biopsy Market Size by Country (2017-2022)
    5.2 Americas Cancer Biopsy Market Size by Type (2017-2022)
    5.3 Americas Cancer Biopsy Market Size by Application (2017-2022)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Cancer Biopsy Market Size by Region (2017-2022)
    6.2 APAC Cancer Biopsy Market Size by Type (2017-2022)
    6.3 APAC Cancer Biopsy Market Size by Application (2017-2022)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
7 Europe
    7.1 Europe Cancer Biopsy by Country (2017-2022)
    7.2 Europe Cancer Biopsy Market Size by Type (2017-2022)
    7.3 Europe Cancer Biopsy Market Size by Application (2017-2022)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Cancer Biopsy by Region (2017-2022)
    8.2 Middle East & Africa Cancer Biopsy Market Size by Type (2017-2022)
    8.3 Middle East & Africa Cancer Biopsy Market Size by Application (2017-2022)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Global Cancer Biopsy Market Forecast
    10.1 Global Cancer Biopsy Forecast by Regions (2023-2028)
        10.1.1 Global Cancer Biopsy Forecast by Regions (2023-2028)
        10.1.2 Americas Cancer Biopsy Forecast
        10.1.3 APAC Cancer Biopsy Forecast
        10.1.4 Europe Cancer Biopsy Forecast
        10.1.5 Middle East & Africa Cancer Biopsy Forecast
    10.2 Americas Cancer Biopsy Forecast by Country (2023-2028)
        10.2.1 United States Cancer Biopsy Market Forecast
        10.2.2 Canada Cancer Biopsy Market Forecast
        10.2.3 Mexico Cancer Biopsy Market Forecast
        10.2.4 Brazil Cancer Biopsy Market Forecast
    10.3 APAC Cancer Biopsy Forecast by Region (2023-2028)
        10.3.1 China Cancer Biopsy Market Forecast
        10.3.2 Japan Cancer Biopsy Market Forecast
        10.3.3 Korea Cancer Biopsy Market Forecast
        10.3.4 Southeast Asia Cancer Biopsy Market Forecast
        10.3.5 India Cancer Biopsy Market Forecast
        10.3.6 Australia Cancer Biopsy Market Forecast
    10.4 Europe Cancer Biopsy Forecast by Country (2023-2028)
        10.4.1 Germany Cancer Biopsy Market Forecast
        10.4.2 France Cancer Biopsy Market Forecast
        10.4.3 UK Cancer Biopsy Market Forecast
        10.4.4 Italy Cancer Biopsy Market Forecast
        10.4.5 Russia Cancer Biopsy Market Forecast
    10.5 Middle East & Africa Cancer Biopsy Forecast by Region (2023-2028)
        10.5.1 Egypt Cancer Biopsy Market Forecast
        10.5.2 South Africa Cancer Biopsy Market Forecast
        10.5.3 Israel Cancer Biopsy Market Forecast
        10.5.4 Turkey Cancer Biopsy Market Forecast
        10.5.5 GCC Countries Cancer Biopsy Market Forecast
    10.6 Global Cancer Biopsy Forecast by Type (2023-2028)
    10.7 Global Cancer Biopsy Forecast by Application (2023-2028)

11 Key Players Analysis
    11.1 Qiagen N.V.
        11.1.1 Qiagen N.V. Company Information
        11.1.2 Qiagen N.V. Cancer Biopsy Product Offered
        11.1.3 Qiagen N.V. Cancer Biopsy Revenue, Gross Margin and Market Share (2020-2022)
        11.1.4 Qiagen N.V. Main Business Overview
        11.1.5 Qiagen N.V. Latest Developments
    11.2 Illumina, Inc.
        11.2.1 Illumina, Inc. Company Information
        11.2.2 Illumina, Inc. Cancer Biopsy Product Offered
        11.2.3 Illumina, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2020-2022)
        11.2.4 Illumina, Inc. Main Business Overview
        11.2.5 Illumina, Inc. Latest Developments
    11.3 ANGLE Plc
        11.3.1 ANGLE Plc Company Information
        11.3.2 ANGLE Plc Cancer Biopsy Product Offered
        11.3.3 ANGLE Plc Cancer Biopsy Revenue, Gross Margin and Market Share (2020-2022)
        11.3.4 ANGLE Plc Main Business Overview
        11.3.5 ANGLE Plc Latest Developments
    11.4 Myriad Genetics
        11.4.1 Myriad Genetics Company Information
        11.4.2 Myriad Genetics Cancer Biopsy Product Offered
        11.4.3 Myriad Genetics Cancer Biopsy Revenue, Gross Margin and Market Share (2020-2022)
        11.4.4 Myriad Genetics Main Business Overview
        11.4.5 Myriad Genetics Latest Developments
    11.5 Hologic, Inc.
        11.5.1 Hologic, Inc. Company Information
        11.5.2 Hologic, Inc. Cancer Biopsy Product Offered
        11.5.3 Hologic, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2020-2022)
        11.5.4 Hologic, Inc. Main Business Overview
        11.5.5 Hologic, Inc. Latest Developments
    11.6 Biocept, Inc.
        11.6.1 Biocept, Inc. Company Information
        11.6.2 Biocept, Inc. Cancer Biopsy Product Offered
        11.6.3 Biocept, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2020-2022)
        11.6.4 Biocept, Inc. Main Business Overview
        11.6.5 Biocept, Inc. Latest Developments
    11.7 Thermo Fisher Scientific, Inc.
        11.7.1 Thermo Fisher Scientific, Inc. Company Information
        11.7.2 Thermo Fisher Scientific, Inc. Cancer Biopsy Product Offered
        11.7.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2020-2022)
        11.7.4 Thermo Fisher Scientific, Inc. Main Business Overview
        11.7.5 Thermo Fisher Scientific, Inc. Latest Developments
    11.8 Danaher
        11.8.1 Danaher Company Information
        11.8.2 Danaher Cancer Biopsy Product Offered
        11.8.3 Danaher Cancer Biopsy Revenue, Gross Margin and Market Share (2020-2022)
        11.8.4 Danaher Main Business Overview
        11.8.5 Danaher Latest Developments
    11.9 Lucence Diagnostics Pte. Ltd.
        11.9.1 Lucence Diagnostics Pte. Ltd. Company Information
        11.9.2 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product Offered
        11.9.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Revenue, Gross Margin and Market Share (2020-2022)
        11.9.4 Lucence Diagnostics Pte. Ltd. Main Business Overview
        11.9.5 Lucence Diagnostics Pte. Ltd. Latest Developments
    11.10 GRAIL, Inc.
        11.10.1 GRAIL, Inc. Company Information
        11.10.2 GRAIL, Inc. Cancer Biopsy Product Offered
        11.10.3 GRAIL, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2020-2022)
        11.10.4 GRAIL, Inc. Main Business Overview
        11.10.5 GRAIL, Inc. Latest Developments
    11.11 Guardant Health
        11.11.1 Guardant Health Company Information
        11.11.2 Guardant Health Cancer Biopsy Product Offered
        11.11.3 Guardant Health Cancer Biopsy Revenue, Gross Margin and Market Share (2020-2022)
        11.11.4 Guardant Health Main Business Overview
        11.11.5 Guardant Health Latest Developments
    11.12 Exact Sciences Corporation
        11.12.1 Exact Sciences Corporation Company Information
        11.12.2 Exact Sciences Corporation Cancer Biopsy Product Offered
        11.12.3 Exact Sciences Corporation Cancer Biopsy Revenue, Gross Margin and Market Share (2020-2022)
        11.12.4 Exact Sciences Corporation Main Business Overview
        11.12.5 Exact Sciences Corporation Latest Developments
    11.13 Freenome Holdings, Inc.
        11.13.1 Freenome Holdings, Inc. Company Information
        11.13.2 Freenome Holdings, Inc. Cancer Biopsy Product Offered
        11.13.3 Freenome Holdings, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2020-2022)
        11.13.4 Freenome Holdings, Inc. Main Business Overview
        11.13.5 Freenome Holdings, Inc. Latest Developments
    11.14 Oncimmune
        11.14.1 Oncimmune Company Information
        11.14.2 Oncimmune Cancer Biopsy Product Offered
        11.14.3 Oncimmune Cancer Biopsy Revenue, Gross Margin and Market Share (2020-2022)
        11.14.4 Oncimmune Main Business Overview
        11.14.5 Oncimmune Latest Developments
    11.15 Chronix Biomedical, Inc.
        11.15.1 Chronix Biomedical, Inc. Company Information
        11.15.2 Chronix Biomedical, Inc. Cancer Biopsy Product Offered
        11.15.3 Chronix Biomedical, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2020-2022)
        11.15.4 Chronix Biomedical, Inc. Main Business Overview
        11.15.5 Chronix Biomedical, Inc. Latest Developments
    11.16 Personal Genome Diagnostics Inc.
        11.16.1 Personal Genome Diagnostics Inc. Company Information
        11.16.2 Personal Genome Diagnostics Inc. Cancer Biopsy Product Offered
        11.16.3 Personal Genome Diagnostics Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2020-2022)
        11.16.4 Personal Genome Diagnostics Inc. Main Business Overview
        11.16.5 Personal Genome Diagnostics Inc. Latest Developments
12 Research Findings and Conclusion

List of Tables
    Table 1. Cancer Biopsy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of Tissue Biopsies
    Table 3. Major Players of Liquid Biopsies
    Table 4. Major Players of Others
    Table 5. Cancer Biopsy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 6. Global Cancer Biopsy Market Size by Type (2017-2022) & ($ Millions)
    Table 7. Global Cancer Biopsy Market Size Market Share by Type (2017-2022)
    Table 8. Cancer Biopsy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 9. Global Cancer Biopsy Market Size by Application (2017-2022) & ($ Millions)
    Table 10. Global Cancer Biopsy Market Size Market Share by Application (2017-2022)
    Table 11. Global Cancer Biopsy Revenue by Players (2020-2022) & ($ Millions)
    Table 12. Global Cancer Biopsy Revenue Market Share by Player (2020-2022)
    Table 13. Cancer Biopsy Key Players Head office and Products Offered
    Table 14. Cancer Biopsy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 15. New Products and Potential Entrants
    Table 16. Mergers & Acquisitions, Expansion
    Table 17. Global Cancer Biopsy Market Size by Regions 2017-2022 & ($ Millions)
    Table 18. Global Cancer Biopsy Market Size Market Share by Regions (2017-2022)
    Table 19. Americas Cancer Biopsy Market Size by Country (2017-2022) & ($ Millions)
    Table 20. Americas Cancer Biopsy Market Size Market Share by Country (2017-2022)
    Table 21. Americas Cancer Biopsy Market Size by Type (2017-2022) & ($ Millions)
    Table 22. Americas Cancer Biopsy Market Size Market Share by Type (2017-2022)
    Table 23. Americas Cancer Biopsy Market Size by Application (2017-2022) & ($ Millions)
    Table 24. Americas Cancer Biopsy Market Size Market Share by Application (2017-2022)
    Table 25. APAC Cancer Biopsy Market Size by Region (2017-2022) & ($ Millions)
    Table 26. APAC Cancer Biopsy Market Size Market Share by Region (2017-2022)
    Table 27. APAC Cancer Biopsy Market Size by Type (2017-2022) & ($ Millions)
    Table 28. APAC Cancer Biopsy Market Size Market Share by Type (2017-2022)
    Table 29. APAC Cancer Biopsy Market Size by Application (2017-2022) & ($ Millions)
    Table 30. APAC Cancer Biopsy Market Size Market Share by Application (2017-2022)
    Table 31. Europe Cancer Biopsy Market Size by Country (2017-2022) & ($ Millions)
    Table 32. Europe Cancer Biopsy Market Size Market Share by Country (2017-2022)
    Table 33. Europe Cancer Biopsy Market Size by Type (2017-2022) & ($ Millions)
    Table 34. Europe Cancer Biopsy Market Size Market Share by Type (2017-2022)
    Table 35. Europe Cancer Biopsy Market Size by Application (2017-2022) & ($ Millions)
    Table 36. Europe Cancer Biopsy Market Size Market Share by Application (2017-2022)
    Table 37. Middle East & Africa Cancer Biopsy Market Size by Region (2017-2022) & ($ Millions)
    Table 38. Middle East & Africa Cancer Biopsy Market Size Market Share by Region (2017-2022)
    Table 39. Middle East & Africa Cancer Biopsy Market Size by Type (2017-2022) & ($ Millions)
    Table 40. Middle East & Africa Cancer Biopsy Market Size Market Share by Type (2017-2022)
    Table 41. Middle East & Africa Cancer Biopsy Market Size by Application (2017-2022) & ($ Millions)
    Table 42. Middle East & Africa Cancer Biopsy Market Size Market Share by Application (2017-2022)
    Table 43. Key Market Drivers & Growth Opportunities of Cancer Biopsy
    Table 44. Key Market Challenges & Risks of Cancer Biopsy
    Table 45. Key Industry Trends of Cancer Biopsy
    Table 46. Global Cancer Biopsy Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 47. Global Cancer Biopsy Market Size Market Share Forecast by Regions (2023-2028)
    Table 48. Global Cancer Biopsy Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 49. Global Cancer Biopsy Market Size Market Share Forecast by Type (2023-2028)
    Table 50. Global Cancer Biopsy Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 51. Global Cancer Biopsy Market Size Market Share Forecast by Application (2023-2028)
    Table 52. Qiagen N.V. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
    Table 53. Qiagen N.V. Cancer Biopsy Product Offered
    Table 54. Qiagen N.V. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 55. Qiagen N.V. Main Business
    Table 56. Qiagen N.V. Latest Developments
    Table 57. Illumina, Inc. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
    Table 58. Illumina, Inc. Cancer Biopsy Product Offered
    Table 59. Illumina, Inc. Main Business
    Table 60. Illumina, Inc. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 61. Illumina, Inc. Latest Developments
    Table 62. ANGLE Plc Details, Company Type, Cancer Biopsy Area Served and Its Competitors
    Table 63. ANGLE Plc Cancer Biopsy Product Offered
    Table 64. ANGLE Plc Main Business
    Table 65. ANGLE Plc Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 66. ANGLE Plc Latest Developments
    Table 67. Myriad Genetics Details, Company Type, Cancer Biopsy Area Served and Its Competitors
    Table 68. Myriad Genetics Cancer Biopsy Product Offered
    Table 69. Myriad Genetics Main Business
    Table 70. Myriad Genetics Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 71. Myriad Genetics Latest Developments
    Table 72. Hologic, Inc. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
    Table 73. Hologic, Inc. Cancer Biopsy Product Offered
    Table 74. Hologic, Inc. Main Business
    Table 75. Hologic, Inc. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 76. Hologic, Inc. Latest Developments
    Table 77. Biocept, Inc. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
    Table 78. Biocept, Inc. Cancer Biopsy Product Offered
    Table 79. Biocept, Inc. Main Business
    Table 80. Biocept, Inc. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 81. Biocept, Inc. Latest Developments
    Table 82. Thermo Fisher Scientific, Inc. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
    Table 83. Thermo Fisher Scientific, Inc. Cancer Biopsy Product Offered
    Table 84. Thermo Fisher Scientific, Inc. Main Business
    Table 85. Thermo Fisher Scientific, Inc. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 86. Thermo Fisher Scientific, Inc. Latest Developments
    Table 87. Danaher Details, Company Type, Cancer Biopsy Area Served and Its Competitors
    Table 88. Danaher Cancer Biopsy Product Offered
    Table 89. Danaher Main Business
    Table 90. Danaher Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 91. Danaher Latest Developments
    Table 92. Lucence Diagnostics Pte. Ltd. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
    Table 93. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product Offered
    Table 94. Lucence Diagnostics Pte. Ltd. Main Business
    Table 95. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 96. Lucence Diagnostics Pte. Ltd. Latest Developments
    Table 97. GRAIL, Inc. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
    Table 98. GRAIL, Inc. Cancer Biopsy Product Offered
    Table 99. GRAIL, Inc. Main Business
    Table 100. GRAIL, Inc. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 101. GRAIL, Inc. Latest Developments
    Table 102. Guardant Health Details, Company Type, Cancer Biopsy Area Served and Its Competitors
    Table 103. Guardant Health Cancer Biopsy Product Offered
    Table 104. Guardant Health Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 105. Guardant Health Main Business
    Table 106. Guardant Health Latest Developments
    Table 107. Exact Sciences Corporation Details, Company Type, Cancer Biopsy Area Served and Its Competitors
    Table 108. Exact Sciences Corporation Cancer Biopsy Product Offered
    Table 109. Exact Sciences Corporation Main Business
    Table 110. Exact Sciences Corporation Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 111. Exact Sciences Corporation Latest Developments
    Table 112. Freenome Holdings, Inc. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
    Table 113. Freenome Holdings, Inc. Cancer Biopsy Product Offered
    Table 114. Freenome Holdings, Inc. Main Business
    Table 115. Freenome Holdings, Inc. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 116. Freenome Holdings, Inc. Latest Developments
    Table 117. Oncimmune Details, Company Type, Cancer Biopsy Area Served and Its Competitors
    Table 118. Oncimmune Cancer Biopsy Product Offered
    Table 119. Oncimmune Main Business
    Table 120. Oncimmune Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 121. Oncimmune Latest Developments
    Table 122. Chronix Biomedical, Inc. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
    Table 123. Chronix Biomedical, Inc. Cancer Biopsy Product Offered
    Table 124. Chronix Biomedical, Inc. Main Business
    Table 125. Chronix Biomedical, Inc. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 126. Chronix Biomedical, Inc. Latest Developments
    Table 127. Personal Genome Diagnostics Inc. Details, Company Type, Cancer Biopsy Area Served and Its Competitors
    Table 128. Personal Genome Diagnostics Inc. Cancer Biopsy Product Offered
    Table 129. Personal Genome Diagnostics Inc. Main Business
    Table 130. Personal Genome Diagnostics Inc. Cancer Biopsy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 131. Personal Genome Diagnostics Inc. Latest Developments
List of Figures
    Figure 1. Cancer Biopsy Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Cancer Biopsy Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Cancer Biopsy Market Size Market Share by Type in 2021
    Figure 7. Cancer Biopsy in Breast Cancer
    Figure 8. Global Cancer Biopsy Market: Breast Cancer (2017-2022) & ($ Millions)
    Figure 9. Cancer Biopsy in Colorectal Cancer
    Figure 10. Global Cancer Biopsy Market: Colorectal Cancer (2017-2022) & ($ Millions)
    Figure 11. Cancer Biopsy in Cervical Cancers
    Figure 12. Global Cancer Biopsy Market: Cervical Cancers (2017-2022) & ($ Millions)
    Figure 13. Cancer Biopsy in Lung Cancers
    Figure 14. Global Cancer Biopsy Market: Lung Cancers (2017-2022) & ($ Millions)
    Figure 15. Cancer Biopsy in Prostate Cancers
    Figure 16. Global Cancer Biopsy Market: Prostate Cancers (2017-2022) & ($ Millions)
    Figure 17. Cancer Biopsy in Skin Cancers
    Figure 18. Global Cancer Biopsy Market: Skin Cancers (2017-2022) & ($ Millions)
    Figure 19. Cancer Biopsy in Blood Cancers
    Figure 20. Global Cancer Biopsy Market: Blood Cancers (2017-2022) & ($ Millions)
    Figure 21. Cancer Biopsy in Kidney Cancers
    Figure 22. Global Cancer Biopsy Market: Kidney Cancers (2017-2022) & ($ Millions)
    Figure 23. Cancer Biopsy in Others
    Figure 24. Global Cancer Biopsy Market: Others (2017-2022) & ($ Millions)
    Figure 25. Global Cancer Biopsy Market Size Market Share by Application in 2021
    Figure 26. Global Cancer Biopsy Revenue Market Share by Player in 2021
    Figure 27. Global Cancer Biopsy Market Size Market Share by Regions (2017-2022)
    Figure 28. Americas Cancer Biopsy Market Size 2017-2022 ($ Millions)
    Figure 29. APAC Cancer Biopsy Market Size 2017-2022 ($ Millions)
    Figure 30. Europe Cancer Biopsy Market Size 2017-2022 ($ Millions)
    Figure 31. Middle East & Africa Cancer Biopsy Market Size 2017-2022 ($ Millions)
    Figure 32. Americas Cancer Biopsy Value Market Share by Country in 2021
    Figure 33. Americas Cancer Biopsy Consumption Market Share by Type in 2021
    Figure 34. Americas Cancer Biopsy Market Size Market Share by Application in 2021
    Figure 35. United States Cancer Biopsy Market Size Growth 2017-2022 ($ Millions)
    Figure 36. Canada Cancer Biopsy Market Size Growth 2017-2022 ($ Millions)
    Figure 37. Mexico Cancer Biopsy Market Size Growth 2017-2022 ($ Millions)
    Figure 38. Brazil Cancer Biopsy Market Size Growth 2017-2022 ($ Millions)
    Figure 39. APAC Cancer Biopsy Market Size Market Share by Region in 2021
    Figure 40. APAC Cancer Biopsy Market Size Market Share by Application in 2021
    Figure 41. China Cancer Biopsy Market Size Growth 2017-2022 ($ Millions)
    Figure 42. Japan Cancer Biopsy Market Size Growth 2017-2022 ($ Millions)
    Figure 43. Korea Cancer Biopsy Market Size Growth 2017-2022 ($ Millions)
    Figure 44. Southeast Asia Cancer Biopsy Market Size Growth 2017-2022 ($ Millions)
    Figure 45. India Cancer Biopsy Market Size Growth 2017-2022 ($ Millions)
    Figure 46. Australia Cancer Biopsy Market Size Growth 2017-2022 ($ Millions)
    Figure 47. Europe Cancer Biopsy Market Size Market Share by Country in 2021
    Figure 48. Europe Cancer Biopsy Market Size Market Share by Type in 2021
    Figure 49. Europe Cancer Biopsy Market Size Market Share by Application in 2021
    Figure 50. Germany Cancer Biopsy Market Size Growth 2017-2022 ($ Millions)
    Figure 51. France Cancer Biopsy Market Size Growth 2017-2022 ($ Millions)
    Figure 52. UK Cancer Biopsy Market Size Growth 2017-2022 ($ Millions)
    Figure 53. Italy Cancer Biopsy Market Size Growth 2017-2022 ($ Millions)
    Figure 54. Russia Cancer Biopsy Market Size Growth 2017-2022 ($ Millions)
    Figure 55. Middle East & Africa Cancer Biopsy Market Size Market Share by Region in 2021
    Figure 56. Middle East & Africa Cancer Biopsy Market Size Market Share by Type in 2021
    Figure 57. Middle East & Africa Cancer Biopsy Market Size Market Share by Application in 2021
    Figure 58. Egypt Cancer Biopsy Market Size Growth 2017-2022 ($ Millions)
    Figure 59. South Africa Cancer Biopsy Market Size Growth 2017-2022 ($ Millions)
    Figure 60. Israel Cancer Biopsy Market Size Growth 2017-2022 ($ Millions)
    Figure 61. Turkey Cancer Biopsy Market Size Growth 2017-2022 ($ Millions)
    Figure 62. GCC Country Cancer Biopsy Market Size Growth 2017-2022 ($ Millions)
    Figure 63. Americas Cancer Biopsy Market Size 2023-2028 ($ Millions)
    Figure 64. APAC Cancer Biopsy Market Size 2023-2028 ($ Millions)
    Figure 65. Europe Cancer Biopsy Market Size 2023-2028 ($ Millions)
    Figure 66. Middle East & Africa Cancer Biopsy Market Size 2023-2028 ($ Millions)
    Figure 67. United States Cancer Biopsy Market Size 2023-2028 ($ Millions)
    Figure 68. Canada Cancer Biopsy Market Size 2023-2028 ($ Millions)
    Figure 69. Mexico Cancer Biopsy Market Size 2023-2028 ($ Millions)
    Figure 70. Brazil Cancer Biopsy Market Size 2023-2028 ($ Millions)
    Figure 71. China Cancer Biopsy Market Size 2023-2028 ($ Millions)
    Figure 72. Japan Cancer Biopsy Market Size 2023-2028 ($ Millions)
    Figure 73. Korea Cancer Biopsy Market Size 2023-2028 ($ Millions)
    Figure 74. Southeast Asia Cancer Biopsy Market Size 2023-2028 ($ Millions)
    Figure 75. India Cancer Biopsy Market Size 2023-2028 ($ Millions)
    Figure 76. Australia Cancer Biopsy Market Size 2023-2028 ($ Millions)
    Figure 77. Germany Cancer Biopsy Market Size 2023-2028 ($ Millions)
    Figure 78. France Cancer Biopsy Market Size 2023-2028 ($ Millions)
    Figure 79. UK Cancer Biopsy Market Size 2023-2028 ($ Millions)
    Figure 80. Italy Cancer Biopsy Market Size 2023-2028 ($ Millions)
    Figure 81. Russia Cancer Biopsy Market Size 2023-2028 ($ Millions)
    Figure 82. Spain Cancer Biopsy Market Size 2023-2028 ($ Millions)
    Figure 83. Egypt Cancer Biopsy Market Size 2023-2028 ($ Millions)
    Figure 84. South Africa Cancer Biopsy Market Size 2023-2028 ($ Millions)
    Figure 85. Israel Cancer Biopsy Market Size 2023-2028 ($ Millions)
    Figure 86. Turkey Cancer Biopsy Market Size 2023-2028 ($ Millions)
    Figure 87. GCC Countries Cancer Biopsy Market Size 2023-2028 ($ Millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Cancer Biopsy Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Cancer Biopsy Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Cancer Biopsy Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports